Top

Published in:

01-10-2010 | Breast Oncology

Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach

Authors: Mohamed El-Shinawi, MD, Sayed F. Abdelwahab, PhD, Maha Sobhy, MSc, Mohamed A. Nouh, MD, Bonnie F. Sloane, PhD, Mona Mostafa Mohamed, PhD

Published in: Annals of Surgical Oncology | Issue 10/2010

Abstract

Background

In breast cancer patients, venous drainage of the breast may contain cells of immunological importance, tumor cells undergoing dissemination, and other biological factors derived from the tumor microenvironment. Collecting axillary venous blood during modified radical mastectomy and thus before dilution in the circulation may allow us to define biological properties of the tumor microenvironment. Aims were to (1) develop a surgical approach to collect blood from the breast tumor microenvironment through tributaries of the axillary vein and (2) characterize and compare immune cells collected from the axillary vein with those in peripheral blood of breast cancer patients.

Materials and Methods

We enrolled 17 women aged 30–50 years and diagnosed with breast cancer by mammography, ultrasound, and biopsy (stages II–III). All patients were, preoperatively, treatment-naive. During routine surgical dissection, blood was collected in heparin tubes, 10 mL from tributaries of the axillary vein and 10 mL from peripheral blood. Mononuclear cells were separated, and percentages of different leukocyte populations were determined by flow cytometry.

Results

We detected a significant increase in the percentage of total T lymphocytes and T helper cells collected from axillary tributaries, but not in the percentages of cytotoxic T cells, monocytes, natural killer, or B cells compared with peripheral blood.

Conclusions

The present study validated using an intraoperative surgical approach to collect leukocytes drained from the tumor microenvironment through axillary tributaries. Our results showed an increase in the infiltration of total T-lymphocytes and T helper cells in the tumor microenvironment, suggesting that they may contribute to tumor pathogenesis.

Omar S, Khaled H, Gaafar R, et al. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr Health J. 2003;9:448–63.PubMed

Zeeneldin AA, Mohamed AM, Abdel HA, et al. Survival effects of cyclooxygenase-2 and 12-lipooxygenase in Egyptian women with operable breast cancer. Indian J Cancer. 2009;46:54–60.CrossRefPubMed

Denewer A, Setit A, Farouk O. Outcome of pectoralis major myomammary flap for post-mastectomy breast reconstruction: extended experience. World J Surg. 2007;31:1382–6.CrossRefPubMed

Nouh MA Iamail, H, Ali El-Din NH, Bolkainy MN. Lymph node metastasis in breast carcinoma: clinicopathologic correlations in 3747 patients. J Egypt Natl Canc Inst. 2004;16:50–6.

Carroll RG. Arresting metastases during excisional cancer surgery. Lancet Oncol. 2004;5:147–8.CrossRefPubMed

Katsuno H, Zacharakis E, Aziz O, et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol. 2008;15:3083–91.CrossRefPubMed

Okumura Y, Tanaka F, Yoneda K, et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg. 2009;87:1669–75.CrossRefPubMed

Monti M, Catania S, Locatelli E, et al. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer. Breast Cancer Res Treat. 1990;17:77–82.CrossRefPubMed

Aaltomaa S, Lipponen P, Eskelinen M, et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992;28A:859–64.CrossRefPubMed

10.

Georgiannos SN, Renaut A, Goode AW, et al. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery. 2003;134:827–34.CrossRefPubMed

11.

Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605–12.CrossRefPubMed

12.

Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996;56:4625–9.PubMed

13.

Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24:5373–80.CrossRefPubMed

14.

Aspord C, Pedroza-Gonzalez A, Gallegos M, et al. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med. 2007;204:1037–47.CrossRefPubMed

15.

Genestie C, Zafrani B, Asselain B, et al. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res. 1998;18:571–6.PubMed

16.

Bland KI, Vezeridis MT. Modified radical mastectomy with early or delayed breast reconstruction. In: Baker RJ, Fischer JE, eds. Mastery of Surgery. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 614–27.

17.

Ibrahim SA, Abdelwahab SF, Mohamed MM, et al. T cells are depleted in HCV-Induced hepatocellular carcinoma patients: possible role of apoptosis and p53. Egypt J Immunol. 2006;13:11–22.PubMed

18.

Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17–32.CrossRefPubMed

19.

Ladoire S, Arnould L, Apetoh L, et al. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3 + regulatory T cells. Clin Cancer Res. 2008;14:2413–20.CrossRefPubMed

20.

Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–4.CrossRefPubMed

21.

Kohrt HE, Nouri N, Nowels K, et al. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med. 2005;2:e284.CrossRefPubMed

22.

Piersma SJ, Jordanova ES, van Poelgeest MI, et al. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res. 2007;67:354–61.CrossRefPubMed

23.

Macchetti AH, Marana HR, Silva JS, et al. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics. 2006;61:203–8.PubMed

24.

Hung K, Hayashi R, Lafond-Walker A, et al. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med. 1998;188:2357–68.CrossRefPubMed

25.

Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother. 2005;54:721–8.CrossRefPubMed

26.

DeNardo DG, Barreto JB, Andreu P, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009;16:91–102.CrossRefPubMed

27.

Finn OJ. Cancer immunology. N Engl J Med. 2008;358:2704–15.CrossRefPubMed

28.

Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995;55:4140–5.PubMed

29.

Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol. 2004;172:4618–23.PubMed

30.

Stetler-Stevenson M, Mansoor A, Lim M, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood. 1997;89:1708–15.PubMed

31.

Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2:957–64.CrossRefPubMed

32.

Arnould L, Gelly M, Penault-Llorca F, et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? Br J Cancer. 2006;94:259–67.CrossRefPubMed

33.

Pardoll D. Metastasis-promoting immunity: when T cells turn to the dark side. Cancer Cell. 2009;16:81–2.CrossRefPubMed

Title: Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach
Authors: Mohamed El-Shinawi, MD
Sayed F. Abdelwahab, PhD
Maha Sobhy, MSc
Mohamed A. Nouh, MD
Bonnie F. Sloane, PhD
Mona Mostafa Mohamed, PhD
Publication date: 01-10-2010
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 10/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-010-1029-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach

Abstract

Background

Materials and Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2010

Assessing the Volume-Outcome Hypothesis and Region-Level Quality Improvement Interventions: Pancreas Cancer Surgery in Two Canadian Provinces

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

Prospective Assessment of Postoperative Complications and Associated Costs Following Inguinal Lymph Node Dissection (ILND) in Melanoma Patients

Ratio of Metastatic to Resected Lymph Nodes as a Prognostic Factor in Node-Positive Colorectal Cancer

Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma

Inadequate Quality of Surveillance after Curative Surgery for Colon Cancer